Abbreviations used:FDA (Food and Drug Administration), NTP (National Toxicology Program), RP (retinyl palmitate), UV (ultraviolet)
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Environmental Working Group. Available from: URL: http://www.ewg.org/2010sunscreen/. Accessed July 28, 2010.
- Comparative assessment of the toxicology of vitamin A and retinoids in man.Toxicology. 1989; 57: 117-161
- Long-term administration of high dose vitamin A to rats does not cause fetal malformations: macroscopic, skeletal and physicochemical findings.J Nutr. 1996; 126: 973-983
- Evaluation of vitamin A toxicity.Am J Clin Nutr. 1990; 52: 183-202
- UVA photoirradiation of anhydroretinol–formation of singlet oxygen and superoxide.Toxicol Ind Health. 2007; 23: 625-631
- Photoirradiation of retinyl palmitate in ethanol with ultraviolet light–formation of photodecomposition products, reactive oxygen species, and lipid peroxides.Int J Environ Res Public Health. 2006; 3: 185-190
- UVA photoirradiation of retinyl palmitate–formation of singlet oxygen and superoxide, and their role in induction of lipid peroxidation.Toxicol Lett. 2006; 163: 30-43
- Photodecomposition of retinyl palmitate in ethanol by UVA light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides.Chem Res Toxicol. 2005; 18: 129-138
- Cytotoxicity and mutagenicity of retinol with ultraviolet A irradiation in mouse lymphoma cells.Toxicol In Vitro. 2010; 24: 439-444
- Photomutagenicity of anhydroretinol and 5,6-epoxyretinyl palmitate in mouse lymphoma cells.Chem Res Toxicol. 2006; 19: 1435-1440
- Photomutagenicity of retinyl palmitate by ultraviolet A irradiation in mouse lymphoma cells.Toxicol Sci. 2005; 88: 142-149
- Photo-induced DNA damage and photocytotoxicity of retinyl palmitate and its photodecomposition products.Toxicol Ind Health. 2005; 21: 167-175
- Levels of retinyl palmitate and retinol in stratum corneum, epidermis and dermis of SKH-1 mice.Toxicol Ind Health. 2006; 22: 103-112
- Levels of retinyl palmitate and retinol in the stratum corneum, epidermis, and dermis of female SKH-1 mice topically treated with retinyl palmitate.Toxicol Ind Health. 2006; 22: 181-191
- Levels of retinyl palmitate and retinol in the skin of SKH-1 mice topically treated with retinyl palmitate and concomitant exposure to simulated solar light for thirteen weeks.Toxicol Ind Health. 2007; 23: 581-589
Department of Health and Human Services. National Toxicology Program. TR-568: technical report pathology tables and curves. Available from: URL: http://ntp.niehs.nih.gov/index.cfm?objectid=555571BB-F1F6-975E-76F2BC5E369EB6F7. Accessed July 28, 2010.
Department of Health and Human Services. National Toxicology Program. Photocarcinogenesis study of glycolic acid and salicylic acid in SKH-1 mice (simulated solar light and topical application study). Available from: URL: http://ntp.niehs.nih.gov/?objectid=883A96DC-F1F6-975E-72D9D9CF9FB7337C. Accessed July 28, 2010.
- Effects of beta-carotene on ultraviolet induced cancer formation in the hairless mouse skin.Photochem Photobiol. 1977; 25: 211-213
- Inhibition of ultraviolet-induced carcinogenesis by all- trans retinoic acid.J Invest Dermatol. 1981; 76: 178-180
- Enhancement of experimental photocarcinogenesis by topical retinoic acid.Cancer Lett. 1979; 7: 85-90
- Lack of enhancement of experimental photocarcinogenesis by topical retinoic acid.Arch Dermatol Res. 1981; 270: 453-462
- Inhibition of ultraviolet-B skin carcinogenesis by all-trans-retinoic acid regimens that inhibit ornithine decarboxylase induction.Cancer Res. 1983; 43: 171-174
- Topical tretinoin enhances corticosteroid-induced inhibition of tumorigenesis in hairless mice previously exposed to solar simulating radiation.Cancer Lett. 1996; 107: 217-222
- Topical retinoic acid enhances, and a dark tan protects, from subedemal solar-simulated photocarcinogenesis.J Invest Dermatol. 2000; 114: 923-927
- Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin.Br J Dermatol. 1999; 140: 656-660
- Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.N Engl J Med. 1988; 318: 1633-1637
Funding sources: None.
Conflicts of interest: None declared.